Internet Sales of "Research Grade Compounds": The Opioid SR-17018 (SR-17) as an Example
Robert B Raffa, Joseph V Pergolizzi, Eugene Vortsman · 2026
Read Internet Sales of "Research Grade Compounds": The Opioid SR-17018 (SR-17) as an Example by Robert B Raffa, Joseph V Pergolizzi, Eugene Vortsman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13581458.txt.
Description
Robert Raffa, Joseph Pergolizzi, and Eugene Vortsman warned in 2026 about internet sales of so-called research grade compounds, using the opioid SR-17018 as a case study. Sellers claim buyers promise lab use only, yet the products come as tablets, a form handy for human use and awkward for research. The drug agency has flagged such compounds as emerging abuse risks.
SR-17018 was made at Scripps Research to test whether a biased opioid could give pain relief without slowing breathing. It never entered human trials, so almost no human safety data exist. The review gathers lab and animal pharmacology and recounts one emergency doctor's case of a suspected overdose, to show the uncertainty clinicians face.
Catalog record
| CREATOR | Robert B Raffa, Joseph V Pergolizzi, Eugene Vortsman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |